Keywords:
ONCOLOGY
;
GEMCITABINE
;
PANCREATIC-CANCER
;
radiology
;
CANCER PATIENTS
;
CANCER-PATIENTS
;
PREDICTION
;
IMRT
;
nuclear medicine
;
pancreatic cancer
;
CANCER
;
BLOOD
;
NEW-YORK
;
imaging
;
PATIENT
;
NUCLEAR-MEDICINE
;
USA
;
MEDICINE
;
biomarker
;
NUCLEAR
;
outcome
;
cetuximab
Type of Publication:
Meeting abstract published
Deep Link:
http://www.dkfz.de/cgi-bin/sel?http://www.dkfz.de/PublicationManager/Show/ShowAbstract.aspx%3fpublishedId=6177